Procurement Summary
Country: USA
Summary: Olink Explore Ht Services
Deadline: 09 Jul 2026
Posting Date: 01 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144325989
Document Ref. No.: 75N98026Q00721
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Background Information: Myelodysplastic Syndromes are heterogeneous stem cell malignancies characterized by chronic inflammation, peripheral cytopenias, and bone marrow dysplasia. LRBGE preliminary data from targeted proteomic arrays has identified substantial changes in the proteome, including secreted proteins in bone marrow plasma from these patients, that may contribute to disease progression. The program has received Bench to Bedside funding to further interrogate these proteomic changes and identify disease biology and potential therapeutic vulnerabilities.
The Olink Explore HT platform is required because it provides high-throughput, multiplexed protein detection using low-volume primary specimens. Olink is the proprietary manufacturer of the Olink Explore HT platform and associated plates. Although third-party service contractors may theoretically offer related sample-processing support, they would not provide the same Olink Explore HT analysis workflow and may be more expensive while not delivering the same analysis, comparability, or direct platform support required for this project
Notice ID: 75n98026q00721
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: 6505 - drugs and biologicals
NAICS Code: 541380 - Testing Laboratories and Services
Inactive Dates: jul 10, 2026
Inactive Policy: manual
Documents
Tender Notice
Documents.zip